V体育2025版 - CD8+ T-cell memory in tumor immunology and immunotherapy
- PMID: 16824130
- PMCID: PMC1501075
- DOI: 10.1111/j.0105-2896.2006.00391.x (V体育ios版)
CD8+ T-cell memory in tumor immunology and immunotherapy
Abstract
The cellular and molecular mechanisms underlying the formation of distinct central, effector, and exhausted CD8+ T-cell memory subsets were first described in the setting of acute and chronic viral diseases. The role of these T-cell memory subsets are now being illuminated as relevant to the tumor-bearing state. The generation and persistence of productive CD8+ T-cell memory subsets is determined, in part, by antigen clearance, costimulation, responsiveness to homeostatic cytokines, and CD4+ T-helper cells. By contrast, chronic exposure to antigen, negative costimulation, and immunomodulation by CD4+ T regulatory cells corrupt productive CD8+ T memory formation. It has become clear from human and mouse studies that the mere generation of CD8+ T-cell memory is not a 'surrogate marker' for cancer vaccine efficacy. Some current cancer vaccine strategies may fail because they amplify, rather than correct or reset, the corrupted CD8+ memory population VSports手机版. Thus, much of the present effort in the development of vaccines for cancer and chronic infectious diseases is aimed at creating effective memory responses. Therapeutic vaccines for cancer and chronic infectious diseases may achieve consistent efficacy by ablation of the dysfunctional immune state and the provision of newly generated, non-corrupted memory cells by adoptive cell transfer. .
Figures


References
-
- Starnes CO. Coley's toxins in perspective. Nature. 1992;357:11–12. - PubMed
-
- Lambert PH, Liu M, Siegrist CA. Can successful vaccines teach us how to induce efficient protective immune responses? Nat Med. 2005;11:S54–S62. - "V体育官网入口" PubMed
-
- Robinson HL, Amara RR. T cell vaccines for microbial infections. Nat Med. 2005;11:S25–S32. - PubMed
-
- Rosenberg SA. Progress in human tumour immunology and immunotherapy. Nature. 2001;411:380–384. - PubMed (V体育官网)
-
- Boon T, Coulie PG, Van den Eynde BJ, Van der Bruggen P. Human T cell responses against melanoma. Annu Rev Immunol. 2006 doi: 10.1146/annurev.immunol.24.021605. 090733. - PubMed
"V体育官网入口" Publication types
MeSH terms
- "V体育ios版" Actions
- "V体育ios版" Actions
- V体育2025版 - Actions
- Actions (V体育ios版)
"V体育ios版" Substances
- "VSports" Actions
Grants and funding
LinkOut - more resources
Full Text Sources (V体育2025版)
Other Literature Sources
Research Materials